SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* HAYEK ANDREW P (Last) (First) (Middle) C/O SURGICAL CARE AFFILIATES, INC., 520 LAKE COOK ROAD, SUITE 250 (Street) DEERFIELD IL 60015 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Surgical Care Affiliates, Inc. [ SCAI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer
	3. Date of Earliest Transaction (Month/Day/Year) 09/15/2015
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Stock Units								76,271(1)	D
Common Stock	09/15/2015		M		347	A	$10.25	218,439(2)	I	See Explanation of Responses(3)
Common Stock	09/15/2015		S(4)		347	D	$38.02	218,092(2)	I	See Explanation of Responses(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to Purchase Common Stock	$10.25	09/15/2015		M			347	(5)	04/21/2018	Common Stock	347	$0	253,591	I	See Explanation of Responses(3)
Options to Purchase Common Stock	$11.18							(6)	03/24/2020	Common Stock	175,610		175,610	I	See Explanation of Responses(3)
Options to Purchase Common Stock	$8.72							(7)	03/24/2020	Common Stock	43,902		43,902	I	See Explanation of Responses(3)
Options to Purchase Common Stock	$12.41							(8)	05/06/2023	Common Stock	182,926		182,926	I	See Explanation of Responses(3)
Options to Purchase Common Stock	$29.02							(9)	09/17/2024	Common Stock	135,682		135,682	I	See Explanation of Responses(3)
Options to Purchase Common Stock	$38.35							(10)	06/04/2025	Common Stock	102,113		102,113	D

Explanation of Responses:

1. All of the Restricted Stock Units ("RSUs") of the issuer are subject to time-based vesting in equal installments on June 4, 2016, June 4, 2017, June 4, 2018 and June 4, 2019 and are settled on each applicable vesting date.

2. Includes 169,084 shares of Common Stock underlying RSUs. All of the RSUs are subject to time-based vesting. As of September 15, 2015, 68,292 of the RSUs were vested and are settled on the earlier of the individual's termination of employment (as defined in the Plan) or a change in control and the remaining 100,792 RSUs vest in equal installments on September 17, 2015, September 17, 2016, September 17, 2017 and September 17, 2018 and are settled on each applicable vesting date.

3. Mr. Hayek is the sole trustee of the Andrew Hayek 2008 Living Trust, which directly owns all of the securities reported on this line.

4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2015.

5. 180,487 of the options are performance-based options and, as of September 16, 2013, became fully vested. The remaining 73,104 options are time-based options and, as of July 24, 2013, became fully vested.

6. 109,756 of the options are performance-based options and, as of September 16, 2013, became fully vested. The remaining 65,854 options are time-based options which, as of March 24, 2013, were fully vested.

7. All of the options are time-based options which, as of March 24, 2015, were fully vested.

8. All of the options are time-based options which are scheduled to vest in equal installments on May 6, 2014, May 6, 2015, May 6, 2016 and May 6, 2017.

9. All of the options are time-based options which are scheduled to vest in equal installments on September 17, 2015, September 17, 2016, September 17, 2017 and September 17, 2018.

10. All of the options are time-based options which are scheduled to vest in equal installments on June 4, 2016, June 4, 2017, June 4, 2018 and June 4, 2019.

Remarks:

	/s/ Richard L. Sharff, Jr., by power of attorney	09/16/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.